TISSUE-DERIVED MATRIKINE COMPOSITIONS AND METHODS THEREFOR

A composition for topical administration to an epithelium is disclosed. The composition comprises a deconstructed matrisome including one or more enzymatically fragmented peptides derived from biological tissue. The composition further comprises one or more pharmaceutically acceptable or cosmetically acceptable excipients. The deconstructed matrisome may be fragmented through degradation by one or more enzymes to produce the one or more peptides. The one or more peptides may be configured to retain cell signaling ability, thereby promoting one or more of tissue homeostasis, tissue repair, and tissue regeneration. The composition may be used to treat a tissue such as skin tissue exhibiting scarring, acne, eczema, psoriasis, and other skin conditions..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 25. Jan. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

O'NEILL JOHN D [VerfasserIn]
GERMANGUZ IGAL [VerfasserIn]
ARANDA EVELYN [VerfasserIn]
XIONG JENNIFER [VerfasserIn]
KISSEL NATALIA [VerfasserIn]
NICHOLS ALEXANDRA [VerfasserIn]
GADEE EDDIE [VerfasserIn]
NGUYEN RICHARD [VerfasserIn]
DALY DREW [VerfasserIn]
NYE ANDREA [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
A61Q: Specific use of cosmetics or similar toilet prepara (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-01-25, Last update posted on www.tib.eu: 2024-03-06, Last updated: 2024-03-15

Patentnummer:

US2024024431

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000688088